Search CommunityWalk:


Trevigen, Inc.

8405 Helgerman Court
Gaithersburg, MD 20877, USA

Category: BioManufacturing; Research Services & Supplies; Suppliers (CRO)

Used in the following map:

Maryland Biotech Industry Map

Trevigen, Inc. is a biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. Its division Trevigen Cell Assays, (TCA) was established in 2008 to conduct contract research work for the pharmaceutical, biotechnology, government and academic segments of the research market.

Trevigen's products range include: Angiogenesis/Cell Differentiation, Antibodies, Apoptosis, Basement Membrane Proteins, CometAssay®, DNA Damage, Molecular Biology, Oxidative Damage, PARP, Stem Cell Assays and 96 Well Format Kits. Its apoptosis products include: Annexin V Kits, TACS® Annexin V-FITC Kit, TACS® Annexin V-Biotin Kit, MitoShift(TM) Mitochondrial Potential Assay, TACS XL® Kits, etc. Its molecular biology product line offers DNA for Hybridization Solutions, DNA Isolation, Electrophoresis Products and DNA Labeling products.

Trevigen's Cell Differentiation/Angiogenesis product line consists of: Basement Membrane Extract, Cell Invasion/Migration Assay Kits, 3D Culture Assays, Specialized Proteins, Antibodies to Basement Membrane Proteins, Cell Viability/Proliferation Assays and Cell Culture Reagents. The company is the recipient of several SBIR grants from the National Institutes of Health, concerning technology development for the analysis of DNA damage.